In-Out Licensing Screening

In highly competitive business environment, medical device companies are expanding their market share by exploring option for In-Out licensing screening program.

R&D expenses and cost to take molecule to market have risen significantly, so it is difficult to achieve competitive edge. In this scenario companies achieve sustainable growth by strategic business development.

Key Questions

 • What are the best strategies in developing an effective licensing deal?
 • What is the strategic fit company? How to identify it?
 • What is the right value of identified medical device for In-Out licensing?
 • What can be done to optimize licensing deal values through collaborative evaluation?
 • What lessons can be drown from the key successful deals and deal makers of past years?
 • Is there any intellectual property infringement issues related to identified assets?

MRA Group Licensing screening team is comprised of professionals that are specifically dedicated to helping our client develop a pro-active approach to licensing deal. Upon project initiation, we can design a method, execute and deliver results in time bound manner.

How We Help?

 • Exploit In-Out licensing opportunities by identifying windows of opportunity to fill portfolio gaps
 • Analysis of partnership and licensing deals based on clinical stage of development of products
  Evaluate major deal performing segments for business development
 • Provide the insight of how competitors are financed, and the mergers and partnerships that have shaped the medical device industry
 • Assessment of the policies and control procedures used to monitor alliances along with recommended improvements

Analysis Involved:

 • Information Reconnaissance:
      1. Gathering information about targeted therapy area
      2. Therapeutic market information
      3. Providing detailed information about current competitive market scenario and latent demand

 • Portfolio and IP Analysis:
      1. Competitive landscape dashboard development
      2. Targeted companies performance and capabilities
      3. Evaluation of Intellectual Property

 • Device Valuation
      1. Qualitative/Quantitative value of medical device technology
      2. Establish negotiation strategy with the target company
      3. Valuation of technology by considering amount of expenditure and investment made

Business Impact:

 • Client will be equipped with a detailed technical understanding as well as an insight of the commercial aspect of the deal to avoid any unanticipated results at a later stage
 • The strength and weakness highlighted from our team of expert researcher will help client to take more informed decision for business development
 • Client will get deal structure made with commercial aspect and a sound technological and legal stance

Press Esc to close